Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shan M. Pradhan
Observed names:
SHAN M. PRADHAN,
Shan Pradhan
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
University of North Carolina at Chapel Hill,
University of Southern California,
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Children's Hospital Los Angeles
ORCID:
0009-0003-2039-1985
Observed ORCID:
0009-0003-2039-1985
OpenAlex ID:
A5030795176
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
2023
·
Paolo Tarantino
, Biagio Ricciuti
, et al.
·
Nature Reviews Clinical Oncology
·
287
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
2023
·
Wanda Cui
, Rodney P Rocconi
, et al.
·
The Lancet Oncology
·
40
FDA Approval Summary: Vorasidenib for IDH -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery
2025
·
Michael I. Barbato
, Amy K. Barone
, et al.
·
Clinical Cancer Research
·
30
Electronegative Electroretinogram in Mucolipidosis IV
2002
·
Shan M. Pradhan
, La-Ongsri Atchaneeyasakul
, et al.
·
Archives of Ophthalmology
·
25
PDF
Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration
2022
·
Kathleen M. Sullivan
, Graça M. Dores
, et al.
·
JAMA Oncology
·
9
Quantitative Fluorescent RT‐PCR Measurements of Postnatal Calcium Channel Gene Expression in Rat Hippocampal Subfields
1999
·
SHAN M. PRADHAN
, SHUNDI GE
, et al.
·
Annals of the New York Academy of Sciences
·
1
Celecoxib Does Not Delay Cutaneous Wound Healing in Hemophilia B Mice.
2008
·
Shan Pradhan
, Maureane Hoffman
, et al.
·
Blood
Show more works
View as search
Works count:
7
Citation count:
392
H-index:
5
I10-index:
4
Year
Topic
Type